Vitamin D status and treatment in ESKD; links to improved CKD-MBD laboratory parameters in a real-world setting.
ESKD 中維他命 D 狀態與治療;與改善 CKD-MBD 實驗室參數的關聯於真實世界環境中。
Am J Nephrol 2024-09-02
Timing of relapse as a key indicator of steroid-sparing requirements in childhood idiopathic nephrotic syndrome.
兒童特發性腎病綜合症中復發時間作為類固醇減量需求的關鍵指標。
J Nephrol 2024-09-01
A randomized phase 2b trial examined the effects of the glucagon-like peptide-1 and glucagon receptor agonist cotadutide on kidney outcomes in patients with diabetic kidney disease.
一項隨機第2b期試驗研究了胰高血糖素樣肽-1和胰高血糖素受體激動劑 cotadutide 對糖尿病腎病患者腎臟結果的影響。
Kidney Int 2024-09-01
Peripheral Blood Lymphocyte Subgroups in Patients Undergoing Hemodialysis with Medium Cut-Off Membranes and High-Flux Membranes: THE SHE Continuation Study.
使用中切割膜和高通量膜進行血液透析的患者外周血淋巴細胞亞群:THE SHE 繼續研究。
Blood Purif 2024-09-01
CaCl2-citrate regional anticoagulation with CVVHD leads to unwanted chloride loading compared to CVVH with systemic anticoagulation.
CaCl2-檸檬酸區域抗凝與全身抗凝的CVVH相比,CVVHD導致不必要的氯負荷。
Blood Purif 2024-09-01
Familial juvenile hyperuricemic nephropathy: Revisiting the SLC8A1 gene, in a family with a novel terminal gross deletion in the UMOD gene.
家族性青少年高尿酸血症腎病:重新探討 SLC8A1 基因,在一個具有 UMOD 基因新型末端大刪除的家族中。
Nefrologia (Engl Ed) 2024-08-31